3,4-dihydroxyphenylacetic acid has been researched along with Migraine Disorders in 1 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castillo, J | 1 |
| Martínez, F | 1 |
| Suárez, C | 1 |
| Naveiro, J | 1 |
| Lema, M | 1 |
| Noya, M | 1 |
1 other study available for 3,4-dihydroxyphenylacetic acid and Migraine Disorders
| Article | Year |
|---|---|
Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenylacetic acid levels in migraine patients.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Brain; Dopamine; Female; Humans; Male; Middle Age | 1996 |